Related Experiment Videos
[Palliative options for esophageal carcinoma]
1Allgemeines Krankenhaus Altona Hamburg. Friedrich.Hagenmueller@ak-altona.lbk-hh.de
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|October 28, 2005
Summary
Palliative therapy for esophageal carcinoma focuses on rapid dysphagia relief. Esophageal prostheses offer immediate relief but may require reintervention, while self-expanding stents present a lower complication alternative.
Area of Science:
- Gastroenterology
- Oncology
- Interventional Endoscopy
Context:
- Esophageal carcinoma often presents with limited curative options, necessitating palliative treatment.
- Dysphagia is a primary symptom requiring prompt management in advanced esophageal cancer.
- Palliative therapies aim to improve quality of life by alleviating cancer-related symptoms.
Purpose:
- To review and compare various endoscopic palliative treatment modalities for esophageal carcinoma.
- To evaluate the efficacy and complication rates of different interventions for dysphagia and esophagotracheal fistulae.
- To provide guidance on selecting appropriate palliative therapies based on patient prognosis and disease characteristics.
Summary:
- Endoscopic prosthesis implantation provides rapid dysphagia relief in 90% of esophageal carcinoma patients but has a 30% reintervention rate.
- Self-expanding stents offer an alternative with lower complication rates compared to traditional plastic prostheses.
- Endoscopic laser therapy is suitable for short stenoses, while endoluminal brachytherapy is effective for longer-term palliation in select patients.
- Palliative chemotherapy and radiochemotherapy are reserved for cases with dominant metastatic symptoms.
Impact:
- Highlights the immediate efficacy of endoscopic prostheses for dysphagia palliation.
- Identifies self-expanding stents as a potentially safer alternative to plastic prostheses.
- Clarifies the indications for different endoscopic interventions and systemic therapies in esophageal cancer palliation.
- Informs clinical decision-making for optimizing palliative care in esophageal carcinoma management.